{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:24:40Z","timestamp":1649096680070},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4,15]]},"DOI":"10.2146\/news120025","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T18:18:27Z","timestamp":1333390707000},"page":"628-628","source":"Crossref","is-referenced-by-count":0,"title":["Lucinactant approved for respiratory distress syndrome"],"prefix":"10.1093","volume":"69","author":[{"given":"Kate","family":"Traynor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/8\/628\/28360980\/ajhp0628.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T23:50:35Z","timestamp":1555113035000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/8\/628\/5112165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,15]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,4,15]]}},"URL":"https:\/\/doi.org\/10.2146\/news120025","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,4,15]]},"published":{"date-parts":[[2012,4,15]]}}}